{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:37:42Z","timestamp":1793306262612,"version":"4.5.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["painjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.pain.2013.08.015","type":"journal-article","created":{"date-parts":[[2013,8,20]],"date-time":"2013-08-20T16:30:27Z","timestamp":1377016227000},"page":"2794-2800","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Intradialytic clearance of opioids: Methadone versus hydromorphone"],"prefix":"10.1097","volume":"154","author":[{"given":"Ryan","family":"Perlman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hili","family":"Giladi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista","family":"Brecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Ware","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence E.","family":"Hebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoram","family":"Shir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R5-31-20210112","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/00000542-200005000-00038","article-title":"Insidious intoxication after morphine treatment in renal failure: delayed onset of morphine-6-glucoronide action.","volume":"92","author":"Angst","year":"2000","journal-title":"Anesthesiology"},{"key":"R10-31-20210112","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0885-3924(94)00121-Z","article-title":"Hydromorphone metabolite accumulation in renal failure letter.","volume":"10","author":"Babul","year":"1995","journal-title":"J Pain Symptom Manage"},{"key":"R15-31-20210112","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1093\/ndt\/12.12.2802","article-title":"Removal of morphine but not fentanyl during haemodialysis letter.","volume":"12","author":"Bastani","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"R20-31-20210112","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/cc2872","article-title":"Acute renal failuredefinition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.","volume":"8","author":"Bellomo","year":"2004","journal-title":"Crit Care"},{"key":"R25-31-20210112","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1002\/(SICI)1097-0142(20000501)88:9<2164::AID-CNCR24>3.0.CO;2-5","article-title":"Validation of the edmonton symptom assessment scale.","volume":"88","author":"Chang","year":"2000","journal-title":"Cancer"},{"key":"R30-31-20210112","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/hup.630","article-title":"The effects of methadone and its role in fatalities.","volume":"19","author":"Corkery","year":"2004","journal-title":"Hum Psychopharmacol"},{"key":"R35-31-20210112","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00520-009-0649-8","article-title":"Early switching from morphine to methadone is not improved by acetaminophen in the analgesia of oncologic patients: a prospective, randomized, double-blind, placebo-controlled study.","volume":"18","author":"Cubero","year":"2010","journal-title":"Support Care Cancer"},{"key":"R40-31-20210112","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2165\/00003088-199631060-00002","article-title":"Pharmacokinetics of opioids in renal dysfunction.","volume":"31","author":"Davies","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"R45-31-20210112","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1053\/j.ajkd.2003.08.025","article-title":"Pain in hemodialysis patients: prevalence, cause, severity and management.","volume":"42","author":"Davison","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R50-31-20210112","first-page":"335","article-title":"Pain management in chronic kidney disease: the pharmacokinetics and pharmacodynamics of hydromorphone and hydromorphone-3-glucuronide in hemodialysis patients.","volume":"4","author":"Davison","year":"2008","journal-title":"J Opioid Manag"},{"key":"R55-31-20210112","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jpainsymman.2004.02.021","article-title":"Opioids in renal failure and dialysis patients.","volume":"28","author":"Dean","year":"2004","journal-title":"J Pain Symptom Manage"},{"key":"R60-31-20210112","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1492-7535.2005.01138.x","article-title":"Hemodialysis adequacy. Basic essentials and practical points for the nephrologists in training.","volume":"9","author":"Depner","year":"2005","journal-title":"Hemodial Int"},{"key":"R65-31-20210112","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0272-6386(00)70339-8","article-title":"Quality-of-life evaluation using the Short-Form 36. Comparison in hemodialysis and peritoneal dialysis patients.","volume":"35","author":"Diaz-Buxo","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"R70-31-20210112","first-page":"81","article-title":"Pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR) in subjects with renal impairment.","volume":"44","author":"Durnin","year":"2001","journal-title":"Proc West Pharmacol Soc"},{"key":"R75-31-20210112","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2165\/00003088-200241140-00003","article-title":"Interindividual variability of the clinical pharmacokinetics of methadoneimplications for the treatment of opioid dependence.","volume":"41","author":"Eap","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"R80-31-20210112","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.phrs.2004.05.002","article-title":"Methadonemetabolism, pharmacokinetics and interactions.","volume":"50","author":"Ferrari","year":"2004","journal-title":"Pharmacol Res"},{"key":"R85-31-20210112","first-page":"85","article-title":"Chronic pain during dialysis. Pharmacologic therapy and its costs.","volume":"51","author":"Fortina","year":"1999","journal-title":"Minerva Urol Nefrol"},{"key":"R90-31-20210112","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/ndt\/14.1.254","article-title":"Methadone is poorly removed by haemodialysis.","volume":"14","author":"Furlan","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"R95-31-20210112","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1155\/2003\/236718","article-title":"Methadone in the treatment of neuropathic pain.","volume":"8","author":"Gagnon","year":"1999","journal-title":"Pain Res Manage"},{"key":"R100-31-20210112","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0885-3924(95)00191-3","article-title":"Oral methadone for managing chronic nonmalignant pain.","volume":"11","author":"Gardner-Nix","year":"1996","journal-title":"J Pain Symptom Manage"},{"key":"R105-31-20210112","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1056-8719(00)00043-5","article-title":"Methadone: a review of its pharmacokinetic and pharmacodynamic properties.","volume":"42","author":"Garrido","year":"1999","journal-title":"J Pharmacol Toxicol Methods"},{"key":"R110-31-20210112","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1176\/ajp.134.8.931","article-title":"Methadone maintenance in a patient on chronic hemodialysis.","volume":"134","author":"Glazer","year":"1977","journal-title":"Am J Psychiatry"},{"key":"R115-31-20210112","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0304-3959(86)90234-4","article-title":"A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer.","volume":"25","author":"Gourlay","year":"1986","journal-title":"PAIN"},{"key":"R120-31-20210112","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/clpt.1988.12","article-title":"Pharmacokinetics and pharmacodynamics of codeine in end-stage renal disease.","volume":"43","author":"Guay","year":"1988","journal-title":"Clin Pharmacol Ther"},{"key":"R125-31-20210112","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/bja\/70.5.511","article-title":"Morphine-6-glucuronide disposition in renal impairment.","volume":"70","author":"Hanna","year":"1993","journal-title":"Br J Anaesth"},{"key":"R130-31-20210112","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1155\/1999\/343209","article-title":"Use of methadone in treating chronic noncancer pain.","volume":"4","author":"Hays","year":"1999","journal-title":"Pain Res Manage"},{"key":"R140-31-20210112","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1213\/00000539-199802000-00049","article-title":"Nondialyzability of fentanyl with high-efficiency and high-flux membranes letter.","volume":"86","author":"Joh","year":"1998","journal-title":"Anesth Analg"},{"key":"R145-31-20210112","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0376-8716(80)90180-5","article-title":"Methadone use in patients with chronic renal disease.","volume":"5","author":"Kreek","year":"1980","journal-title":"Drug Alcohol Depend"},{"key":"R150-31-20210112","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/jama.2012.9289","article-title":"Methadone overdose deaths rise with increased prescribing for pain.","volume":"308","author":"Kuehn","year":"2012","journal-title":"JAMA"},{"key":"R155-31-20210112","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/oxfordjournals.annonc.a010679","article-title":"Patient-controlled analgesia with oral methadone in cancer pain: preliminary report.","volume":"7","author":"Mercadante","year":"1996","journal-title":"Ann Oncol"},{"key":"R160-31-20210112","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jpainsymman.2005.01.007","article-title":"Hydromorphone.","volume":"29","author":"Murray","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"R165-31-20210112","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/clpt.1981.172","article-title":"Methadone disposition in patients with chronic liver disease.","volume":"30","author":"Novick","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R170-31-20210112","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1530-0277.1985.tb05558.x","article-title":"Effect of severe alcoholic liver disease on the disposition of methadone in maintenance patients.","volume":"9","author":"Novick","year":"1985","journal-title":"Alcohol Clin Exp Res"},{"key":"R175-31-20210112","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1136\/bmj.292.6535.1548","article-title":"Morphine intoxication in renal failure: the role of morphine-6-glucuronide.","volume":"292","author":"Osborne","year":"1986","journal-title":"Br Med J"},{"key":"R180-31-20210112","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/bod.2510090207","article-title":"Pharmacokinetics of hydromorphone after intravenous, peroral and rectal administration to human subjects.","volume":"9","author":"Parab","year":"1988","journal-title":"Biopharm Drug Dispos"},{"key":"R185-31-20210112","first-page":"8749","article-title":"Pharmacokinetic considerations in the hemodialysis of drugs.","volume":"7","author":"Parker","year":"1982","journal-title":"J Clin Hosp Pharm"},{"key":"R190-31-20210112","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0304-3959(86)90091-6","article-title":"Chronic use of opioid analgesics in non-malignant pain: report of 38 cases.","volume":"25","author":"Portenoy","year":"1986","journal-title":"PAIN"},{"key":"R195-31-20210112","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0304-3959(83)90126-4","article-title":"The validation of visual analogue scales as ratio scale measures for chronic and experimental pain.","volume":"17","author":"Price","year":"1983","journal-title":"PAIN"},{"key":"R200-31-20210112","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/clpt.1988.167","article-title":"Hydromorphone levels and pain control in patients with severe chronic pain.","volume":"44","author":"Reidenberg","year":"1988","journal-title":"Clin Pharmacol Ther"},{"key":"R205-31-20210112","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00002508-199812000-00013","article-title":"Oral methadone for the treatment of severe pain in hospitalized children: a report of five cases.","volume":"14","author":"Shir","year":"1998","journal-title":"Clin J Pain"},{"key":"R210-31-20210112","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/BF03020377","article-title":"Methadone is safe for treating hospitalized patients with severe pain.","volume":"48","author":"Shir","year":"2001","journal-title":"Can J Anaesth"},{"key":"R215-31-20210112","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/0091270011416364","article-title":"Design, conduct, analysis, and interpretation of clinical studies in patients with impaired kidney function.","volume":"52","author":"Tortorici","year":"2012","journal-title":"J Clin Pharmacol"},{"key":"R220-31-20210112","doi-asserted-by":"crossref","first-page":"133","DOI":"10.36076\/ppj.2008\/11\/S133","article-title":"Opioid pharmacology.","volume":"11","author":"Trescot","year":"2008","journal-title":"Pain Physician"},{"key":"R230-31-20210112","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s005200000183","article-title":"Hydromorphone: pharmacology and clinical applications in cancer patients.","volume":"9","author":"Sarhill","year":"2001","journal-title":"Support Care Cancer"},{"key":"R235-31-20210112","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1089\/jpm.2004.7.545","article-title":"Hydromorphone neuroexcitation.","volume":"7","author":"Thwaites","year":"2004","journal-title":"J Palliat Med"},{"key":"R240-31-20210112","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/j.1552-4604.1981.tb05693.x","article-title":"Pharmacokinetics and bioavailability of hydromorphone following intravenous and oral administration to human subjects.","volume":"4","author":"Vallner","year":"1981","journal-title":"J Clin Pharmacol"},{"key":"R245-31-20210112","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","article-title":"A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity.","volume":"34","author":"Ware","year":"1996","journal-title":"Med Care"},{"key":"R255-31-20210112","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0024-3205(01)01133-X","article-title":"Hydromorphone-3-glucuronide: a more potent neuro-excitant than its structural analogue, morphine-3-glucuronide.","volume":"69","author":"Wright","year":"2001","journal-title":"Life Sci"}],"container-title":["Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1016\/j.pain.2013.08.015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T06:10:46Z","timestamp":1646374246000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006396-201312000-00031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1016\/j.pain.2013.08.015","relation":{},"ISSN":["0304-3959"],"issn-type":[{"value":"0304-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intradialytic clearance of opioids: Methadone versus hydromorphone","name":"articletitle","label":"Article Title"},{"value":"PAIN\u00ae","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.pain.2013.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}